Otros idiomas Pangenomic Health Inc.

Acciones

NARA

CA69842E3041

Mercado cerrado - Canadian Securities Exchange Otros sitios de cotización 21:35:48 21/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,08 ^CAD	-11,11 %		-33,33 %	-60,00 %

16/02	Pangenomic Health Inc. anuncia cambios en su junta directiva	CI
2023	Pangenomic Health Inc. informa de los resultados del tercer trimestre y los nueve meses finalizados el 30 de septiembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

PanGenomic Health Announces Application for a Management Cease Trade Order For Late Filing of Audited Annual Financial Statements	13/04
PanGenomic Health Announces Completion of Consolidation	21/03
CSE Bulletin: Consolidation - PanGenomic Health Inc. (NARA)	19/03
PanGenomic Health Announces Proposed Consolidation and Completion of Withdrawal from AQSE	18/03
PanGenomic Health Announces Withdrawal from AQSE	20/02
PanGenomic Health plans to withdraw shares from Aquis Stock Exchange	19/02
PanGenomic Health Announces Changes to Board of Directors	16/02
Pangenomic Health Inc. Announces Changes to Board of Directors	16/02
PanGenomic Health agrees non-binding drawdown facility with Crescita	09/01
PanGenomic Health Signs Letter of Intent with Crescita Capital for $5 Million Equity Drawdown Facility	09/01
PanGenomic subsidiary reveals point-of-care vitamin D test	06/12
PanGenomic Health Subsidiary Introducing Point-of-Care Vitamin D Test for Dental Implant Industry	06/12
PanGenomic Health Subsidiary Introduces Point-of-Care Vitamin D Test for the Dental Implant Industry	06/12
Pangenomic Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29/11
How Technology Can Be a Game Changer in Mental Health Treatment and AI Is Leading the Way	22/11
PanGenomic Health's MUJN sells first biomarker tests	17/11
PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests	17/11
PanGenomic Health Intends to Close Shares for Debt Settlement	01/11
PanGenomic Health interim loss widens amid higher costs	30/08/23
PanGenomic Health Announces Financial Results for Half Year Ended June 30, 2023	30/08/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Pangenomic Health Inc.

Acciones

NARA

CA69842E3041

Otros idiomas

Filtros